Assertio Therapeutics, Inc 8-K SEC Filings

Filed On	Filing
22 May 2020	8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
11 May 2020	8-K: Results of Operations and Financial Condition; Other Events
24 Apr 2020	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
21 Apr 2020	8-K: Other Events
08 Apr 2020	8-K: Regulation FD Disclosure
17 Mar 2020	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
11 Mar 2020	8-K: Regulation FD Disclosure
09 Mar 2020	8-K: Results of Operations and Financial Condition
20 Feb 2020	8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
13 Feb 2020	8-K: Other Events
07 Feb 2020	8-K: Entry into a Material Definitive Agreement; Other Events
13 Jan 2020	8-K: Completion of Acquisition or Disposition of Assets; Results of Operations and Financial Condition +1 more
12 Dec 2019	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
06 Nov 2019	8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities
21 Oct 2019	8-K: Regulation FD Disclosure
30 Sep 2019	8-K: Departure/Election of Directors or Officers; Compensation
14 Aug 2019	8-K: Regulation FD Disclosure
09 Aug 2019	8-K: Departure/Election of Directors or Officers; Compensation
09 Aug 2019	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
07 Aug 2019	8-K: Results of Operations and Financial Condition

Comments